Z6尊龙
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2021.03.30
关于开展外汇衍生品生意的可行性剖析报告
2021.03.30
未来三年(2021年-2023年)股东回报妄想
2021.03.30
内部控制规则落实自查表
2021.03.30
关于深圳市多普乐实业生长有限公司2020年度业绩允许完成情形的说明
2021.03.30
2020年度监事会事情报告
2021.03.30
2020年度财务决算报告
2021.03.30
关于举行2020年度业绩网上说明会并征集相关问题的通告
2021.03.30
第五届监事会第四次聚会决议通告
2021.03.30
关于召开2020年年度股东大会的通知通告
2021.03.30
中天堂富证券有限公司关于Z6尊龙2020年度召募资金存放与使...
第一页
上一页
19
20
21
22
23
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.
【网站地图】
【sitemap】